2021
DOI: 10.7171/jbt.21-3203-013
|View full text |Cite
|
Sign up to set email alerts
|

Improving Performance of a SARS-CoV-2 RT-LAMP Assay for Use With a Portable Isothermal Fluorimeter: Towards a Point-of-Care Molecular Testing Strategy

Abstract: Frequent and accessible testing is a critical tool to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To develop low-cost rapid tests, many researchers have used reverse transcription loopmediated isothermal amplification (RT-LAMP) with fluorescent readout. Fluorescent LAMP-based assays can be performed using cost-effective, portable, isothermal instruments that are simpler to use and more rugged than polymerase chain reaction (PCR) instruments. However, false-positive resul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 12 publications
0
8
0
Order By: Relevance
“…Furthermore, reaction vessels remain closed, and amplicons never need to be manipulated for analysis, reducing the likelihood of environmental crosscontamination [73]. Successful implementation and validation of the RT-LAMP assay on the Axxin T8 has overcome the challenges of adapting assays to point-of-care instruments [36] and shows the potential of the use of this workflow near the point-of-care. FDA Emergency Use Authorization and widespread use of the Lucira COVID-19 All-In-One Test Kit at the time of publication illustrates the potential for similar technologies to be translated for true point-of-care use.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Furthermore, reaction vessels remain closed, and amplicons never need to be manipulated for analysis, reducing the likelihood of environmental crosscontamination [73]. Successful implementation and validation of the RT-LAMP assay on the Axxin T8 has overcome the challenges of adapting assays to point-of-care instruments [36] and shows the potential of the use of this workflow near the point-of-care. FDA Emergency Use Authorization and widespread use of the Lucira COVID-19 All-In-One Test Kit at the time of publication illustrates the potential for similar technologies to be translated for true point-of-care use.…”
Section: Discussionmentioning
confidence: 99%
“…For RT-LAMP reactions run on the Axxin T8-ISO (T8), assay components described above were doubled to achieve 50 μL reaction volumes with two exceptions [36]: fluorescent dye was used at a 5X concentration instead of 50X [37], and 0.2 μL of Tte UvrD helicase (NEB) was included with each reaction [38,39]. Reactions contained 10 μL of sample unless otherwise noted.…”
Section: Rt-lamp Reactionsmentioning
confidence: 99%
“…(1) Mobile thermostats for 0.2-mL tubes with real-time detection of the amplification signal [ 13 , 65 , 120 , 121 ].…”
Section: Discussionmentioning
confidence: 99%
“…Other enzymes successfully adapted for the LAMP method include the UvrD helicase [ 64 , 65 ], which can reduce the background amplification, as well as uracil-DNA glycosylase [ 66 ], which is used in PCR technology to prevent contamination by amplification products.…”
Section: Enzymes For the Lamp Methodsmentioning
confidence: 99%
“…Therefore, the facility for the probe-based LAMP methods is more likely to be more costly than the traditional LAMP methods. It is worth noting that some portable fluorescence analyzers and isothermal fluorimeters with minimal laboratory resources are currently available or under development (Supplementary Table S1) [70][71][72][73][74][75]. Furthermore, end-point fluorescence detection requires much less instrumentation than real-time monitoring.…”
Section: Comparison Of the Probe-based Lamp Methods With The Traditio...mentioning
confidence: 99%